Volume 10, Number 7—July 2004
Research
Detection of SARS-associated Coronavirus in Throat Wash and Saliva in Early Diagnosis
Table 1
Patient IDa | Sampling dayb | Copies/5 mL throat wash (% of total) |
|
---|---|---|---|
Cell-free component | Cell-associated component | ||
1 |
d2 |
848,000 (99.6) |
2,982 (0.4) |
2 |
d3 |
34,320 (99.7) |
85 (0.3) |
3 |
d3 |
10,680 (99.7) |
34 (0.3) |
4 |
d3 |
119,500 (98.8) |
1,495 (1.2) |
5 |
d3 |
18,160 (99.6) |
72 (0.4) |
6 |
d4 |
14,400 (95.4) |
695 (4.6) |
7 |
d4 |
631,280 (99.9) |
416 (0.1) |
8 |
d4 |
19,900 (99.4) |
124 (0.6) |
9 |
d4 |
17,800 (99.5) |
91 (0.5) |
10 |
d5 |
40,500 (99.9) |
60 (0.1) |
11 |
d5 |
3,152,000 (99.2) |
25,146 (0.8) |
12 |
d6 |
1,896,000 (99.4) |
12,160 (0.6) |
13 |
d6 |
11,100 (99.6%) |
40 (0.4) |
14 |
d6 |
5,992 (99.4) |
35 (0.6) |
16 |
d8 |
33,400,000 (88.8) |
4,222,000 (11.2) |
17 | d9 | 13,192 (97.5) | 330 (2.5) |
aPatients of probable SARS were diagnosed according to the World Health Organization clinical definitions (15).
bSampling day 2 (d2) is the second day of fever.
Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.